financetom
Business
financetom
/
Business
/
Emera CFO Blunden Appointed Executive VP Finance for U.S. Subsidiary
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Emera CFO Blunden Appointed Executive VP Finance for U.S. Subsidiary
Mar 19, 2025 6:17 AM

08:45 AM EDT, 03/19/2025 (MT Newswires) -- Emera ( EMRAF ) on Wednesday said Greg Blunden, the company's chief financial officer since 2016, has been appointed executive vice president finance for Emera USA.

Blunden will oversee finance for Tampa Electric and Peoples Gas, Emera's ( EMRAF ) largest and fastest-growing utilities. Demand in Florida for electricity and gas services continues to grow and it is where 80% of Emera's ( EMRAF ) $20 billion capital plan will be invested over the next five years, the company said.

Blunden will remain as CFO until a replacement is appointed.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Akebia Therapeutics Says EMA Panel Recommends Approval of Xoanacyl for Chronic Kidney Disease Treatment
Akebia Therapeutics Says EMA Panel Recommends Approval of Xoanacyl for Chronic Kidney Disease Treatment
Apr 3, 2025
10:01 AM EDT, 04/03/2025 (MT Newswires) -- Akebia Therapeutics ( AKBA ) said Thursday that the European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Xoanacyl for treating elevated serum phosphorus and iron deficiency in adults with chronic kidney disease. The company said Averoa, a biopharmaceutical company specializing in renal treatments, licensed the rights from Akebia...
Jewellery maker Pandora sees annual impact from US tariffs of $178 mln
Jewellery maker Pandora sees annual impact from US tariffs of $178 mln
Apr 3, 2025
COPENHAGEN, April 3 (Reuters) - Danish jewellery maker Pandora said on Thursday it estimates the total impact of U.S. tariffs on the company to be around 1.2 billion crowns ($178.34 million) per year, with the impact in 2025 to be around 700 million crowns. ($1 = 6.7288 Danish crowns) ...
Amneal Pharmaceuticals' Crexont Added to Three Insurance Coverage Accounts
Amneal Pharmaceuticals' Crexont Added to Three Insurance Coverage Accounts
Apr 3, 2025
10:02 AM EDT, 04/03/2025 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) said Thursday that the Veterans Administration, UnitedHealthcare (UNH), and CVS Health ( CVS ) have added Parkinson's disease treatment Crexont to their national prescription drug formularies. The company said the additional coverage increases the total US insurance coverage of Crexont to more than 50% of covered patients from...
Copyright 2023-2026 - www.financetom.com All Rights Reserved